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Background/aim: Reducing lymphedema-associated burden and disability in the pediatric setting requires improved awareness and
understanding clinical properties of the lymphedema. The aim of this study was to evaluate the clinical and demographic characteristics
of patients with pediatric lymphedema presented to different lymphedema centers in Turkey.
Materials and methods: The socio-demographic and clinical characteristics of the children including age, gender, presence of genetic
syndromes, duration of edema, site and stage of lymphedema and the received therapies were determined. Parental and children
education on self-management techniques were recorded.
Results: A total of 122 children (female: 66, male: 56) with a mean age of 120.7 ± 71.2 months were included from 7 centers. Of them;
92% had primary, 8% had secondary lymphedema mostly due to infection and trauma. Lymphedema was part of a syndrome in 18%
of the children. The most common site of involvement was the lower extremity, followed by upper extremity and genital involvement.
Lymphedema was complicated in 17 % of children, mainly with a clinical picture of cellulitis, infection, and pain. The median duration
of lymphedema was 41 (5–216) months. Although most of the children had stage 2 lymphedema, only 40% of them received treatment.
The most commonly received treatment was compression therapy. No family or child was educated for self- care management before.
Conclusion: In conclusion, pediatric lymphedema has a comparable gender distribution and usually involves the lower extremities.
Although most of the children had advanced disease, more than half of the patients did not receive any treatment indicating the unmet
need for management of lymphedema. The education of patients and/or children about self-management methods were lacking. We
suggest educational activities for both families of children with lymphedema and health care providers, in order to facilitate early
reference to lymphedema units and to receive prompt preventive and therapeutic approaches for this suffering condition.
Key words: Child lymphedema, clinical, demographic, therapeutic, education

1. Introduction
Lymphedema is a chronic progressive disease characterized
by swelling of the body parts due to the insufficiency of
the lymphatic system which can be seen in both adults
and children [1–3]. Pediatric lymphedema is generally

represented by developmental lymphatic vascular
deficiency which can be either congenital or hereditary but
it rarely occurs in children with an intact lymphatic system,
due to secondary causes consisting infection, trauma, and
other conditions [2–4]. Pediatric primary lymphedema
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may occur as a nonsyndromic inherited condition, or as a
part of syndromic disorders comprising Turner, Noonan,
Prader-Willi, Klippel-Trenaunay, vascular malformations
and etc. [4–8]. In most cases lymphedema is present from
birth, but may also develop later in some cases. The age of
onset (congenital, pubertal), family history, site of swelling,
associated conditions and dysmorphic features and
underlying genetic causes are important in the differential
diagnosis of pediatric lymphedema [2]. Diagnosis of
pediatric lymphedema is based mainly on clinical findings
but physicians have to take detailed anamnesis, perform
an extensive physical examination for coexisting systemic
involvement and secondary causes, and carry out required
imaging modalities [1,2,9–11]. Lymphoscintigraphy is the
gold standard diagnostic technique with 90% sensitivity
and 100% specificity. In recent years, ultrasonography
is gaining popularity in lymphedema diagnosis as a
noninvasive imaging modality [11].
Pediatric lymphedema may affect the extremities,
trunk, genitals, head-face, and rarely the internal organs
[6–10], and cause life-long physical, psychological and
social problems but is still a neglected condition among
physicians [2,6,11–14]. Due to the low awareness about
pediatric lymphedema, the patients may be misdiagnosed
or late-diagnosed in both developed and developing
countries [1,6]. Prevention of progression, early diagnosis,
and proper treatment are crucial in the management
of pediatric lymphedema. Reducing lymphedemaassociated burden and disability in the pediatric setting
requires improved awareness and understanding of the
development and clinical properties of the lymphedema
[4,6,14]. To address these gaps in evidence, we performed
a cross-sectional descriptive multi-center study. The aim
of this study was to evaluate the clinical characteristics
of patients with pediatric lymphedema presented to
lymphedema units in different regions of Turkey.
2. Materials and methods
The study was approved by the ethics committee of the
coordinator university (GO-2018-439/20). The family of
the participants provided written informed consent for data
collection. An invitation letter was sent to 10 lymphedema
centers in different regions of Turkey (registered in
Anatolian Lymphedema Association website-www.
lenfodemdernegi.org.tr), 8 of them replied but 1 of them
could not reach to have least number of patients (n = 5),
therefore 7 centers from 4 cities (University of Hacettepe,
University of Ege, İstanbul Physical Therapy and
Rehabilitation Training and Research Hospital, University
of Cumhuriyet, Bakırköy Sadi Konuk Education and
Research Hospital, University of Celal Bayar and Ankara
Training and Research Hospital) attended to the study.
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All lymphedema patients that were referred to
lymphedema units of these different hospitals, were
screened during April 2018–April 2019, and patients
diagnosed with pediatric lymphedema were included in
the study. The inclusion criteria were; to be 0–18 years
of age and to be diagnosed as lymphedema. Those who
are not willing to participate in the study were excluded.
Diagnosis of primary and secondary lymphedema was
based mainly on anamnesis, physical examination, and
lymphoscintigraphic or ultrasonographic evaluation
[6,15,16] in which researchers have taken standardized
complete anamnesis and performed standardized
extensive physical examination [15] in all centers. The
main researchers from each center were experienced PMR
specialists and members of the Anatolian Lymphedema
Association who delivered or received education for
standardized diagnosis of lymphedema, depending on
consensus documents (6,15,16). The presence of genetic
syndromes, comorbid diseases or vascular anomalies were
recorded from the files of the patients, in which majority
of them were sent from pediatric clinics.
The patient characteristics including age, gender, body
mass index (BMI), comorbid diseases, drugs, performed
imaging modalities, presence of genetic syndromes, family
history, as well as the education level and monthly income
of the parents were recorded. Lymphedema characteristics
comprising duration of lymphedema, site of lymphedema,
limb involvement, stage of lymphedema according to ISL
criteria [16], pitting of edema, Stemmer sign positivity
(checking the thickness of dermis and fibrosis by lifting
the skin on dorsum of fingers [1,15]), complications
(infection, cellulitis, papillomatosis, wound, pain) and the
received therapies (complete decongestive therapy (CDT),
bandaging, manual lymphatic drainage (MLD), skin care,
self-management techniques, pneumatic compression
pumps, exercise and other therapies like drugs and
alternative therapies) for lymphedema were determined.
For parents, the education about parental self-management
techniques to control swelling and reduce complications
was also assessed [14,17].
As gender differences in regard to epidemiology,
involvement site, and associated syndromic conditions,
may exist in pediatric lymphedema; we additionally
analyzed our data according to gender.
2.1. Statistical analysis
The analysis of the demographic and clinical data was
conducted by descriptive statistics. Normality of continuous
variables was evaluated by the Kolmogorov–Smirnov
test. All the continuous variables were following normal
distribution. Accordingly, continuous data were described
(mean + SD) and analyzed using parametric statistics. The
categorical variables were recorded as frequencies (n) and
percentages (%) and were compared using the Fisher’s
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exact test. Differences between male and female patients
were examined using student’s t tests for continuous
and Fisher’s exact test for categorical variables. Pearson
(r), Spearman (rs) or Eta (rpb) correlation coefficient was
used to evaluate the correlation between the duration of
lymphedema and demographic or clinical parameters. A
two-sided p < 0.05 was considered statistically significant.
All analyzes were performed with SPSS 22.0 and p < 0.05
was considered significant.
3. Results
A total of 122 pediatric lymphedema patients who had
referred to the predetermined lymphedema centers during
12 months were recruited to the study. The distribution
of the number of patients by centers were as follows:
University of Hacettepe: 46 (37.7%); University of Ege:
19 (15.6%); İstanbul Physical Therapy and Rehabilitation
Training and Research Hospital: 19 (15.6%); Ankara
Training and Research Hospital: 14 (11.4%); Bakırköy
Sadi Konuk Education and Research Hospital: 13 (10.6%);
University of Celal Bayar: 5 (4%) and University of
Cumhuriyet: 5 (4%). The majority of the patients (73%)
were sent from outpatient clinics of pediatric departments,
while 27% of them were sent from outpatient clinics of
Physical Medicine and Rehabilitation departments to the
lymphedema units of these centers.
According to demographical properties; the female/
male ratio was comparable (66/56) with a median age of
126 (min: 5–max: 160) months. The average duration of
edema was 63 months with a median value of 40 (2–216)
months. Family history was present in 14.7% of children.
Lymphedema was part of a syndrome in 18% of the
children and most of the patients had no genetic analysis.
Nearly half of them (51%) had lymphoscintigraphic
evaluation while 58% of them had US results as a diagnostic
imaging modality. The most commonly used drugs were
oral or topical antibiotics and antifungal agents. Most
of the parents’ education level was high school followed
by primary school. The monthly income was low in the
majority of the families. Table 1 indicated the sociodemographical properties of the study group.
Regarding the lymphedema properties; the majority
of the children (92%) had primary lymphedema, while
8.2% of them had secondary lymphedema. The identified
causes in children with secondary lymphedema were
mainly trauma (marble fall, vehicle accident), infection
(phlebitis during intravenous drug therapy, sepsis) and
drugs (sirolimus), as recorded from the files. The most
common site of involvement was lower extremity, followed
by upper extremity and majority of them had unilateral
limb involvement. Comorbid internal organ involvement
consisting protein losing enteropathy, gastrointestinal,
genitourinary involvement, and lung disease were

determined from files of 8% of patients. Children who
had genital lymphedema was 11% and male patients were
more likely than female patients in which 3% of them had
hydrocele surgery. Stemmer sign was positive in 76% of
them and most of them had stage 2 lymphedema, with
spontaneous irreversible grade. The characteristics of
lymphedema are shown in Table 2. Lymphedema was
complicated in 17% of children, mainly with a clinical
picture of cellulitis, infection, and pain.
Considering the treatments; only 40% of children
reported receiving treatment. The most common
treatment was compression therapy including bandaging
and pressure garments, and MLD, respectively. Surgical
operation for lymphedema was performed on 2% of the
children, mainly for the lymphedema in the genital area.
As with other therapies; 8 children got oral or topical
antibiotics and/or antifungal therapies, and 1 of them got
leech therapy. No family or children was educated in selfcare management before.
There was a statistically significant difference between
male and female children only in regard to age (Table 3).
Female patients were more likely to be older, but the other
variables were similar between gender groups.
The duration of lymphedema was correlated with stage
(rs: 0.345, p < 0.001) and grade (rs: 0.363, p < 0.001) of
lymphedema and as well as with Stemmer sign positivity
(rpb: 0.774, p = 0.03) and BMI (r: 0.291, p: 0.003) (Table 4).
4. Discussion
Our study group with 122 children; had a comparable
gender distribution and majority of our patients had
primary lymphedema usually involving the lower
extremities. Lymphedema was part of a syndrome in
18% of the children and complicated in 17% of them,
commonly with a clinical picture of infection and pain.
Although most of the children had stage-2 lymphedema,
only 40% of them received treatment which was mainly the
compression therapies. No family or child was educated
for self-care management before.
Lymphedema is a rare condition affecting
approximately 1.15–4 in 10,000 children and adolescents
(5,16) but is frequently misdiagnosed and unrecognized
due to the heterogeneous clinical picture and the natural
variable course [6,14,18]. There are limited series in
the literature defining the clinical characteristics and
progressive course of the disease in patients with pediatric
lymphedema [3,5,18–20]. As far as we have known, this is
the first study that presents the clinical and demographical
characteristics of Turkish pediatric lymphedema patients.
The etiology of pediatric lymphedema commonly
depends on congenital primary conditions but conditions
like trauma, infection, drugs, lipedema, Kawasaki
syndrome may also cause secondary lymphedema in
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Table 1. The sociodemographical characteristics of the participants.
Patients (n = 122)
Age (month)

120.74 ± 71.29

Gender
Female

66 (54%)

Male

56 (46%)

BMI (kg/m )

20.60 ± 5.46

Duration of lymphedema (month)

63.97 ± 58.7

Education of caregiver

Mother

Father

Illiterate

3 (2.5%)

1 (0.8%)

Primary school

52 (43.0%)

28 (23.3%)

High School

50 (41.3%)

59 (49.2%)

University

16 (13.2)

32 (26.7)

2

Drugs
Absent

91 (74.6%)

Antibiotics/antimycotics (topical/oral)

24 (19.7%)

Diosmin hesperidin

3 (2.5%)

Sirolimus

4 (3.3%)

Presence of genetic syndrome
Present

22 (15.4%)

Absent

100 (69.9%)

Turner syndrome

8 (5.6%)

Down syndrome

3 (2.1%)

Digeorge syndrome

1 (0.7%)

Klippel Trenaunay Syndrome

1 (0.7%)

Hannekam syndrome

1 (0.7%)

Milroy disease

4 (2.8%)

Meige’s disease

3 (2.1%)

Family history
Present

18 (14.8%)

Absent

104 (85.2%)

Imaging used for diagnosis
Lymphoscintigraphy
Absent

60 (49.2%)

Present

62 (50.8%)

Ultrasonography
Absent

51 (41.8%)

Present

71 (58.2%)

Monthly income (Turkish lira)
<1000

4 (4.8%)

1000–3000

39 (46.4%)

3000–5000

30 (35.2%)

5000–7000

3 (3.6%)

˃7000

8 (9.5%)

BMI: Body mass index
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Table 2. The clinical properties of lymphedema in all participants.
n = 122
Etiology
Primary
Secondary
Site of lymphedema
Lower extremity
Upper extremity
Trunk
Genital
Head &face
İnternal organ
Limb involvement
Unilateral
Bilateral
Internal organ involvement
Absent
Respiratory system
Gastrointestinal system
Genitourinary system
Stage of lymphedema
Stage 0
Stage 1
Stage 2
Stage 3
Pitting
Positive
Negative
Stemmer sign
Positive
Negative
Complications
Absent
Present
Pain
Cellulitis
Papillomatosus skin changes
Wound
Treatment
None
Skin care
Manual lymphatic drainage
Bandaging
Compression garment
Pump
Exercise
Self-care methods
Surgery
Other

112 (91.8)
10 (8.2%)
106 (86.9%)
27 (22.1%)
2 (1.6%)
14 (11.5%)
4 (3.3%)
8 (6.6%)
39 (32.0%)
83 (68.0%)
112 (91.8%)
3 (2.5%)
5(4.1%)
2 (1.6%)
5 (4.1%)
42 (34.4%)
70 (57.4%)
5 (4.1%)
46 (37.7%)
76 (62.3%)
93 (76.2%)
29 (23.8%)
101 (82.8%)
21 (17.2%)
19 (15.6%)
17 (13.9%)
3 (2.5%)
2 (1.6%)
73 (59.8%)
30 (24.6%)
23 (18.9%)
35 (28.7%)
29 (23.8%)
1 (0.8%)
22 (18.0%)
0 (0.0%)
2 (1.6%)
8 (6.6%)

children [7,18–22]. The previous series reported that
86% to 93% of the children had primary lymphedema,
and secondary causes of pediatric lymphedema were
mostly reported as trauma, infection, sepsis, drugs like
sirolimus, and sodium valproate. [5,18,19,22]. In our
study group, we have determined 92% of children with
primary lymphedema and the main reasons for secondary
lymphedema were mostly the trauma and infection.
Rarely, the lymphedema can be a part of a systemic
syndrome and, pleural and pericardial effusions,
ascites, chylous effusions, and pulmonary and intestinal
lymphangiectasia can manifest as feature of a more
widespread lymphatic problem [10,18,22,23]. Accurate
diagnosis is a major concern in pediatric lymphedema
as the symptoms may also resemble or misdiagnose with
conditions like hemihypertrophy or vascular anomalies
[7,22,23]. The association of primary lymphedema with
congenital genetic syndromes has been reported with
a ratio between 16%–33% in earlier series [4,6,18–20].
Family history of lymphedema is important in congenital
primary lymphedema and was determined in 14%–27%
of the pediatric patients in the literature [3,5,18–20]. Our
data indicated that family history was present in 14% of the
children while, congenital genetic anomalies or systemic
syndromes were present in 18% of them, as recorded
from their files. Most of our patients did not undergo
genetic screening for mutations during their assessment
in pediatric wards. We did not further analyze the genetic
mutations as this point was not the primary aim of our
study. Accordingly, the frequency of congenital diseases
like Milroy or Meige’s disease may have underestimated in
our study group.
Primary pediatric lymphedema is commonly seen in
female children and some studies reported the ratio of
female pediatric lymphedema as 59%–78% [3,5,20,21–26].
In our study group, the distribution of female and male
children with primary lymphedema was comparable
with a ratio of 54/46. The extremities, mainly the lower
extremity was the most commonly affected site in the
literature [3,18,20] but the upper extremity, abdomen,
genital area, and trunk were also involved in previous
studies [3,5,20]. Schook et al. [19] reported extremity
lymphedema in 95% of their patients of which half of them
had bilateral and 18% had additional genital swelling. The
bilateral involvement was similar between their male and
female pediatric patients. Watt et al. [18] indicated 94%
of patients with lower limb involvement and 15% of them
had genital lymphedema. The ratio of unilateral to bilateral
extremity involvement varied from approximately 1:1 to
3:1 in previous reports [4,6,19]. We have determined
unilateral/bilateral extremity involvement as 2/1,
which was comparable to previous data. The majority
of our population had primary lymphedema in the
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Table 3. The difference of clinical and demographical variables between male and female pediatric
patients.
Female (n = 66)

Male (n = 56)

P values

Age (month)

139.67 ± 66.59

99.12 ± 70.9

0.002*1

BMI (kg/m2)

21.30 ± 5.56

19.80 ± 5.39

0.1531

Involvement site

0.2301

Leg

59

47

Arm

13

14

Genital

5

9

Trunk

2

0

Head/face

3

1

Internal organ

3

7

Duration of disease (month)

68.77 ± 57.90

59.24 ± 59.89

Stage of lymphedema

0.4531
0.8002

Stage 0

3

2

Stage 1

20

22

Stage 2

40

30

Stage 3

3

2

Grade of lymphedema

0.6262

Reversible

20

23

Spontaneous irreversible

45

32

Elephantiasis

1

1

Complications

1.0002

Present

2

1

Absent

10

7

Treatment

0.0712

None

33

40

Skin care

22

8

Bandaging

22

13

Manual lymphatic drainage

14

9

Compression garment

20

9

Pump

1

0

Exercise

16

6

Self-care

0

0

Other

7

3

Monthly income (Turkish lira)

0.6392

<2000

3

2

2000–3000

23

26

3000–5000

19

14

5000–7000

11

5

˃7000

10

8

BMI: Body mass index, *p < 0.05, female vs. male group, 1Student t-test, 2: Fisher’s exact test
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Table 4. Correlation between the duration of lymphedema and other clinical factors.
Stage
The duration of lymphedema

Grade

Stemmer sign positivity

BMI

2

r: 0.345

r: 0.363

r: 0.774

r: 0.2913

p: 0.0009

p: 0.0009

p: 0.030

p: 0.003

1

1

: Spearman correlation coefficient
: Point-biserial correlation coefficient
3
: Pearson correlation coefficient
1
2

extremities. We have determined 86.8% of lower extremity
involvement followed by upper extremity (22.1%) and
genital involvement (11.4%).
Lower extremity lymphedema commonly begins from
the dorsum of the foot and the edema is usually pitting in
early stage. With the progression of the disease, the edema
becomes nonpitting and Stemmer sign (unable to pinch the
fold of skin on the dorsum of phalanges) can be detected as
positive indicating progressed disease [1,2,6]. We recorded
pitting in only 38% of our patients and Stemmer sign
positivity was %76 in our study group which indicates the
fibrosis and advanced stage of the extremity lymphedema.
Most of our study participants had stage 2 lymphedema
with spontaneous irreversible type. None of the previous
studies indicated the stage of their patients but reported
the complications of lymphedema that indirectly show the
progressed disease.
Lymphedema is a chronic condition and several
complications including pain, infection, wounds,
lymphorrhea, may develop and lead to physical disabilities
[1–3]. A common complication of pediatric lymphedema
is the repeated attacks of cellulitis and lymphangitis
which was reported in 12%–22% of cases with primary
lymphedema [3,5,18–21]. A previous study [18] reported
complications of lymphedema in 73% of their patients,
most commonly as fibrosis followed by cellulitis and
pain. Schook et al. [19] reported cellulitis in 19% of their
patients in which recurrent infections were also common.
In our study we have determined complications in 17% of
children; cellulitis and pain being the most common ones.
Genital lymphedema in pediatric population is
common and previous series determined the frequency
of genital lymphedema as 8%–18% among children with
primary lymphedema [3,19,23,24]. There was a male
predominance in the involvement of the genital area in the
majority of the studies and most of them had concomitant
lower extremity involvement [19,20,24]. The most common
complication of genital lymphedema was cellulitis, and the
surgical debulking procedures were performed in 36%–
44%, resulted in improved symptoms and appearance
[3,18,19,24]. We have observed genital lymphedema
in 11.7% of our patients, and 64% of them were male.
Patients (2%) had surgery with improved clinical picture.

Surgical management of genital lymphedema especially in
male children is not uncommon [23–25]. A previous study
reported that 34 of 56 patients with genital involvement
required surgical management, with emphasizing the risk
of operation in lymphoedematous tissues and supporting
the earlier performance of conservative management [24].
In our study the surgical operations for treatment were
performed for only male genital lymphedema.
The diagnosis of lymphedema in children is often
delayed and there are difficulties to reach to the proper care
and management [6,16,26]. There are several studies that
have enlightened the delay for diagnosis and treatment
of pediatric lymphedema [2,5,6,13–15,20]. We did not
determine the duration of diagnosis as timing was not clear
in some of our study group. But according to the clinical
examination findings, and the stage of lymphedema; we can
comment that most of the children had advanced disease,
which may indirectly indicate the delayed diagnosis and/
or treatment. The delay in diagnosis and treatment may be
due to the relative rarity of the condition, heterogeneous
clinical picture, lack of awareness and information about
the condition, and lack of available services for the care
and management of lymphedema in our region [27].
There is no cure for this lifelong condition, but CDT (skin
care, manual lymphatic drainage, multilayer bandaging,
exercise, pressure garments, self-care education) as a gold
standard of lymphedema treatment, reduce the volume,
decrease the incidence of complications and improve
quality of life [1,2,13,27,28]. The CDT principles resemble
to those for adults but some modifications may be needed
in compression degrees and pressure garments. In addition,
self-care management techniques are the cornerstone of
the therapy and long-term well-being. Pediatric specific
management strategies should include teaching parents
to take active role in management, encouraging normal
physical activity, and the inclusion of psychosocial
support among children [1,13,29,30]. During the lifelong maintenance phase, compliance and adherence of
children to self-management are essential to provide the
adequate symptom control. According to our results more
than half of the patients did not receive any therapy before,
and none of them was educated for self-care management
methods. In other words; self-management education was
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neglected and missed, despite 40% of them received at least
one component of CDT. Therefore, health professionals
should be educated on the importance and teaching of
self-care methods in children with lymphedema. The
most common treatment was recorded as compression
therapies including bandaging and pressure garments,
followed by skin-care and MLD. The majority of pediatric
patients in previous retrospective studies were reported to
receive compression therapies and MLD, supporting our
data [3,5,18,19]. There is no pharmacological therapy for
lymphedema that have proven benefit, in contrast some
drugs may worsen the disease [29,30]. The used drugs in
our study were commonly prescribed for the complications
of lymphedema and comorbid vascular anomalies.
Although pediatric lymphedema is rare, the impact
on the lives of the children and their families is great.
Children growing up with lymphedema can struggle
during key developmental stages and have to cope with
a physical disability, to struggle with low self-esteem, and
social and lifestyle restrictions. This can be even harder
for the families who are desperate to understand what is
happening to their child, and who are seeking for the true
diagnosis, information, and suitable management for their
child’s condition [6,14,17,20]. In addition, they have to
struggle to manage the financial problems related to the
treatments [6,14,17,19]. In our study, most of the families
had low monthly income according to the economic status
of the country. In Turkey the CDT therapies in government
hospitals are free but the materials used in bandaging are
not reimbursed. More importantly, the pressure garments
that need to be changed every 6 months in the maintenance
phase, are reimbursed at about 30% rate. All these points
lead to difficulties in reaching the proper treatments and
maintaining the improvements in the long-term base. The
relatively small study group and the cross-sectional design
of the study are the limitations of our study. But as far as we

have known this is the first study evaluating the detailed
demographic and clinical variables for this population,
which may highlight the unmet need for the early diagnosis
and proper management of pediatric lymphedema patients
in a developing country. The multicenter design may also
strengthen our results. We hope the results of our study
help to improve the health care delivery settings in order to
enhance the quality of life of these patients, as a strategical
approach of the government.
In conclusion pediatric lymphedema has a comparable
gender distribution and usually involves the lower
extremities in our study group. The duration of the disease
was long and more than half of patients had spontaneous
irreversible lymphedema at submission. Although most of
the children had advanced disease, more than half of the
patients did not receive any treatment indicating the unmet
need for management of lymphedema. The education
of the parents and/or children about self-management
methods were lacking. We suggest educational activities
for both families of children with lymphedema and health
care providers, in order to facilitate early reference to
lymphedema units and, to receive prompt preventive and
therapeutic approaches for this suffering condition.
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